跳至主要内容
临床试验/NCT03211585
NCT03211585Unknown不适用

EVALUATION OF THE EFFECT OF THE PERFECTA V-BEAM LASER ON ROSACEA (FACIAL REDNESS, TELANGIECTASIAS AND PHOTODAMAGE)

Syneron Medical0 个研究点目标入组 20 人开始时间: 2016年10月最近更新:
适应症

试验速览

阶段
不适用
入组人数
20
主要终点
The percentage reduction in the facial redness and telangiectasias of rosacea

研究概览

简要总结

The purpose of this study is to further quantify the safety and effectiveness of the Syneron-Candela long pulse-duration, extended sub-pulse, larger spot-size prototype Perfecta V-Beam, 595nm laser system for the treatment of facial redness associated with flushing and blushing, or rosacea. The Perfecta laser system is expected to provide effective treatment of rosacea with less bruising or purpura and greater effectiveness than previous generation systems. This study should enable optimization of treatment parameters for using the Perfecta 595nm laser for treating rosacea.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subjects must have a Fitzpatrick skin type of I-IV and have Rosacea as evaluated by the treating physician.
  • Subjects must have visible telangiectasia on the side of the face.
  • Subjects must be willing and able to comply with all follow-up requirements.
  • Subjects must be willing and able to apply sunblock SPF of 30 while exposed to the sun.
  • Subject willing to have photographs taken and used in presentations or publications.

排除标准

  • Subjects must not have had a previous laser treatment, deep chemical peel in the intended treatment site(s) within 6 months prior to treatment, oral retinoids within 6 months of their inclusion into this study or have ever taken gold therapy.
  • Subjects must not have a history of keloid formation.
  • Subjects with Fitzpatrick Classification of V or VI (to reduce the risk of hyper-pigmentation).
  • Subjects must be willing and able to comply with all follow-up requirements.
  • Subjects cannot have vitiligo, a condition where pigment is lost in the skin and white patches appear).
  • Subjects not willing to avoid sun exposure or not will to apply sunblock SPF of 30 while exposed to the sun.
  • Subject not willing to have photographs taken and used in presentations, publications and marketing material

结局指标

主要结局

The percentage reduction in the facial redness and telangiectasias of rosacea

时间窗: two months following the final treatment

The percentage reduction in the facial redness and telangiectasias of rosacea will be determined by the investigators using polarized photography for each subject

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

相似试验